BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7998789)

  • 21. Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update.
    Holmøy T; Harbo H; Vartdal F; Spurkland A
    Curr Mol Med; 2009 Jun; 9(5):591-611. PubMed ID: 19601809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes.
    Beall SS; Biddison WE; McFarlin DE; McFarland HF; Hood LE
    J Neuroimmunol; 1993 Jun; 45(1-2):53-60. PubMed ID: 8101191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
    Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
    Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple susceptibility loci for multiple sclerosis.
    Haines JL; Bradford Y; Garcia ME; Reed AD; Neumeister E; Pericak-Vance MA; Rimmler JB; Menold MM; Martin ER; Oksenberg JR; Barcellos LF; Lincoln R; Hauser SL;
    Hum Mol Genet; 2002 Sep; 11(19):2251-6. PubMed ID: 12217953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen studies in multiple sclerosis.
    Hillert J
    Ann Neurol; 1994; 36 Suppl():S15-7. PubMed ID: 8017880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
    Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
    Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
    Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
    Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
    González-Enríquez GV; Torres-Mendoza BM; Márquez-Pedroza J; Macías-Islas MA; Ortiz GG; Cruz-Ramos JA
    Immunogenetics; 2018 Aug; 70(8):547-551. PubMed ID: 29397401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis susceptibility: population and twin study of polymorphisms in the T-cell receptor beta and gamma genes region. French Group on Multiple Sclerosis.
    Briant L; Avoustin P; Clayton J; McDermott M; Clanet M; Cambon-Thomsen A
    Autoimmunity; 1993; 15(1):67-73. PubMed ID: 8105988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.
    Haines JL; Terwedow HA; Burgess K; Pericak-Vance MA; Rimmler JB; Martin ER; Oksenberg JR; Lincoln R; Zhang DY; Banatao DR; Gatto N; Goodkin DE; Hauser SL
    Hum Mol Genet; 1998 Aug; 7(8):1229-34. PubMed ID: 9668163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA and multiple sclerosis: population and families study.
    Govaerts A; Gony J; Martin-Mondiére C; Poirier JC; Schmid M; Schuller E; Degos JD; Dausset J
    Tissue Antigens; 1985 Apr; 25(4):187-99. PubMed ID: 3874450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alpha genes of the T cell receptor: a possible implication in genetic susceptibility to multiple sclerosis].
    Martell M; Marcadet A; Strominger J; Dausset J; Cohen D
    C R Acad Sci III; 1987; 304(5):105-10. PubMed ID: 3101996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis in the Faroe Islands. VI. Studies of HLA markers.
    Jersild C; Kurtzke JF; Riisom K; Heltberg A; Arbuckle J; Hyllested K
    Tissue Antigens; 1993 Aug; 42(2):105-10. PubMed ID: 7903488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of multiple sclerosis.
    Ebers GC; Dyment DA
    Semin Neurol; 1998; 18(3):295-9. PubMed ID: 9817533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of HLA in MS Susceptibility and Phenotype.
    Greer JM
    Curr Top Behav Neurosci; 2015; 26():1-27. PubMed ID: 25502788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
    Khankhanian P; Matsushita T; Madireddy L; Lizée A; Din L; Moré JM; Gourraud PA; Hauser SL; Baranzini SE; Oksenberg JR
    BMC Med Genet; 2015 Jul; 16():55. PubMed ID: 26212423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple sclerosis--a disease with complex genetics].
    Myhr KM; Harbo HF
    Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2723-6. PubMed ID: 14600746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
    Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
    Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.